home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Heterozygous Mutations In TREX1 Cause Familial Chilblain Lupus And Dominant Aicardi-Goutières Syndrome (Abstract)

  April, 5 2007 8:34
your information resource in human molecular genetics
Heterozygous Mutations In TREX1 Cause Familial Chilblain Lupus And Dominant Aicardi-Goutières Syndrome

Published in: American Journal of Human Genetics, 80:811-815, 2007.

Gillian Rice, William G. Newman, John Dean, Teresa Patrick, Rekha Parmar, Kim Flintoff, Peter Robins, Scott Harvey, Thomas Hollis, Ann O'Hara, Ariane L. Herrick, Andrew P. Bowden, Fred W. Perrino, Tomas Lindahl, Deborah E. Barnes, and Yanick J. Crow

Contact Author:
Yanick J. Crow, Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds, United Kingdom, and Department of Paediatrics, St Luke's Hospital, Bradford, United Kingdom


TREX1 constitutes the major 35 DNA exonuclease activity measured in mammalian cells. Recently, biallelic mutations in TREX1 have been shown to cause Aicardi-Goutières syndrome at the AGS1 locus. Interestingly, Aicardi-Goutières syndrome shows overlap with systemic lupus erythematosus at both clinical and pathological levels. Here, we report a heterozygous TREX1 mutation causing familial chilblain lupus. Additionally, we describe a de novo heterozygous mutation, affecting a critical catalytic residue in TREX1, that results in typical Aicardi-Goutières syndrome.

(C) American Journal of Human Genetics.

Posted by: Tressie Dalaya

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.